Genomic Valley Biotech Limited, a active public limited company, was established on 16 May 1994 in Jhajjar, Haryana, India. Engaging in biotechnology within the agriculture, forestry, fishing sector, it holds CIN: L01122HR1994PLC033029. Registered under ROC Roc Delhi. it is listed on BSE: 539206. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹3.05 Cr.
It upholds a compliant status. In 2022, it reported revenue of ₹1.55 M and a net worth of ₹2.88 Cr. Its leadership includes Satendra Kumar Goyal (Director), Parul Agrawal (Director), Ashok Kumar (Additional Director). Past directors included Rajesh Kumar Jha, Satendra Kumar Goyal, Sunil Kumar. It holds no open charges and ₹3.74 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at 4 K.M.Stone, Berri Chharra Road Vill. Kherka,Musalman,P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, 124507.
L01122HR1994PLC033029
033029
16 May 1994
₹9.00 Cr
₹3.05 Cr
Roc Delhi
Listed (BSE: 539206)
Active
Explore comprehensive insights into Genomic Valley Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satendra Kumar Goyal | Director | 09 May 2024 | Current |
| Parul Agrawal | Director | 14 Feb 2024 | Current |
| Ashok Kumar | Additional Director | 14 Nov 2023 | Current |
| Yogainder Kumar Gupta | Additional Director | 30 May 2025 | Current |
| Yogesh Agrawal | Managing Director | 07 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo(Kmp) | 31 May 2016 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genomic Valley Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.74% decrease. The company also saw a substantial improvement in profitability, with a 98.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Genomic Valley Biotech had a promoter holding of 67.85% and a public holding of 32.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹37,388,077.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2021 | Others | ₹2.26 Cr | Satisfied |
| 30 Apr 2019 | Others | ₹1.48 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Genomic Valley Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Genomic Valley Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomic Valley Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Yogainder Kumar Gupta was appointed as a Additional Director was appointed as a Additional Director on 30 May 2025 & has been associated with this company since 5 months 27 days . was documented.
Genomic Valley Biotech Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was recorded as a recent event.
Satendra Kumar Goyal was appointed as a Director was appointed as a Director on 09 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Genomic Valley Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Parul Agrawal was appointed as a Director was appointed as a Director on 14 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
The activity Ashok Kumar was appointed as a Additional Director was appointed as a Additional Director on 14 Nov 2023 & has been associated with this company since 2 years 11 days . was completed.
The CIN of Genomic Valley Biotech Limited is L01122HR1994PLC033029.
Genomic Valley Biotech Limited is headquartered at 4 K.M.Stone, Berri Chharra Road Vill. Kherka,Musalman,P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, 124507.
Genomic Valley Biotech Limited was incorporated on 16 May 1994.
The current directors of Genomic Valley Biotech Limited are
The primary industry of Genomic Valley Biotech Limited is Agriculture, Forestry, Fishing.
Genomic Valley Biotech Limited is listed. It is listed on BSE: 539206.
The authorized capital of Genomic Valley Biotech Limited is ₹9.00 Cr, and the paid-up capital is ₹3.05 Cr.
The compliance status of Genomic Valley Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX